Clinical Trials Directory

Trials / Completed

CompletedNCT00521703

Evaluation of Topical Lidocaine Spray as Adjuvant to Upper Gastrointestinal Endoscopy in Children

Evaluation of Topical Lidocaine Spray as Adjuvant to Upper Gastrointestinal Endoscopy in Children and Teenagers

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
78 (actual)
Sponsor
Hospital Infantil Cândido Fontoura · Academic / Other
Sex
All
Age
8 Years – 18 Years
Healthy volunteers
Not accepted

Summary

There is some controversy in the medical literature regarding the effectiveness of topical lidocaine in children as an adjuvant drug to upper gastrointestinal endoscopy. In children, deep sedation and general anesthesia are often used to sedate children submitting to this procedure. Propofol is an anesthetic drug increasingly popular in this situation, but this drug can only be used with an anesthesiologist in Brazil. Its main side effects include hypotension, respiratory depression and local pain. Lidocaine is frequently used as premedication, and the rationale is that lowering patient discomfort could lower the required dose to achieve the endoscopy and reduce potential side effects. Nevertheless, some patients perceive this medication as uncomfortable. This study aims to compare sedative drug doses between patients who were given either placebo or topical lidocaine.

Detailed description

This study is a randomized double-blind placebo-controlled clinical trial. Primary outcome: propofol doses required to achieve adequate sedation. Population: children submitting to upper digestive endoscopy, weight \> 30 kg and age between 8 and 18 years. Exclusion criteria: neurological disorders, psychiatric disorders, specific contra-indication to either lidocaine or propofol. Estimated sample: 160 patients. Placebo: tannic acid 0.5%

Conditions

Interventions

TypeNameDescription
DRUGLidocaineoral cavity and throat were sprayed with lidocaine 10% two to three puffs before propofol infusing
DRUGTannic acidoral cavity and throat were sprayed with placebo (tannic acid 0.5%) two to three puffs before propofol infusing

Timeline

Start date
2007-08-01
Completion
2008-04-01
First posted
2007-08-28
Last updated
2008-05-23

Locations

1 site across 1 country: Brazil

Source: ClinicalTrials.gov record NCT00521703. Inclusion in this directory is not an endorsement.